Retrospective cohort study of usage patterns of epidural injections for spinal pain in the US fee-for-service Medicare population from 2000 to 2014

• Published in: BMJ open Vol. 6; no. 12; p. e013042
• Main Authors: Manchikanti, Laxmaiah, Pampati, Vidyasagar, Hirsch, Joshua A
• Format: Journal Article
• Language: English
• Published: England BMJ Publishing Group LTD 01.12.2016; BMJ Publishing Group
• Subjects: Age Distribution; Aged; Aged, 80 and over; Centers for Medicare and Medicaid Services (U.S.); Chronic Pain - drug therapy; Databases, Factual; Fee-for-Service Plans; Female; Health Services Research; Humans; Injections, Epidural - trends; Lumbosacral Region; Male; Medicare; Pain management; Pain Management - methods; Population; Retrospective Studies; Studies; Surgery; United States; Use statistics; United States > US
• DOI: 10.1136/bmjopen-2016-013042
• ISSN: 2044-6055

ObjectiveTo assess the usage patterns of epidural injections for chronic spinal pain in the fee-for-service (FFS) Medicare population from 2000 to 2014 in the USA.DesignA retrospective cohort.MethodsThe descriptive analysis of the administrative database from Centers for Medicare and Medicaid Services (CMS) Physician/Supplier Procedure Summary (PSPS) master data from 2000 to 2014 was performed. The guidance from Strengthening the Reporting of Observational studies in Epidemiology (STROBE) was applied. Analysis included multiple variables based on the procedures, specialties and geography.ResultsOverall epidural injections increased 99% per 100 000 Medicare beneficiaries with an annual increase of 5% from 2000 to 2014. Lumbar interlaminar and caudal epidural injections constituted 36.2% of all epidural injections, with an overall decrease of 2% and an annual decrease of 0.2% per 100 000 Medicare beneficiaries. However, lumbosacral transforaminal epidural injections increased 609% with an annual increase of 15% from 2000 to 2014 per 100 000 Medicare population.ConclusionsUsage of epidural injections increased from 2000 to 2014, with a decline thereafter. However, an escalating growth has been seen for lumbosacral transforaminal epidural injections despite numerous reports of complications and regulations to curb the usage of transforaminal epidural injections.